Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: E9AW15
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006644 | phospholipid metabolic process | 4 | 1 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 1 |
GO:0006654 | phosphatidic acid biosynthetic process | 6 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0008610 | lipid biosynthetic process | 4 | 1 |
GO:0008654 | phospholipid biosynthetic process | 5 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019637 | organophosphate metabolic process | 3 | 1 |
GO:0042592 | homeostatic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 1 |
GO:0046473 | phosphatidic acid metabolic process | 6 | 1 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 1 |
GO:0046486 | glycerolipid metabolic process | 4 | 1 |
GO:0048878 | chemical homeostasis | 4 | 1 |
GO:0055088 | lipid homeostasis | 5 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090407 | organophosphate biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0016746 | acyltransferase activity | 3 | 1 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 1 |
GO:0016787 | hydrolase activity | 2 | 2 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0042171 | lysophosphatidic acid acyltransferase activity | 6 | 1 |
GO:0052689 | carboxylic ester hydrolase activity | 4 | 1 |
GO:0071617 | lysophospholipid acyltransferase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 325 | 329 | PF00656 | 0.232 |
CLV_C14_Caspase3-7 | 372 | 376 | PF00656 | 0.329 |
CLV_NRD_NRD_1 | 163 | 165 | PF00675 | 0.385 |
CLV_NRD_NRD_1 | 23 | 25 | PF00675 | 0.620 |
CLV_NRD_NRD_1 | 273 | 275 | PF00675 | 0.322 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.558 |
CLV_PCSK_KEX2_1 | 163 | 165 | PF00082 | 0.385 |
CLV_PCSK_KEX2_1 | 23 | 25 | PF00082 | 0.561 |
CLV_PCSK_KEX2_1 | 273 | 275 | PF00082 | 0.322 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.580 |
CLV_PCSK_PC7_1 | 24 | 30 | PF00082 | 0.437 |
CLV_PCSK_SKI1_1 | 220 | 224 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 246 | 250 | PF00082 | 0.280 |
CLV_PCSK_SKI1_1 | 282 | 286 | PF00082 | 0.165 |
CLV_PCSK_SKI1_1 | 310 | 314 | PF00082 | 0.283 |
CLV_PCSK_SKI1_1 | 48 | 52 | PF00082 | 0.450 |
DEG_MDM2_SWIB_1 | 279 | 287 | PF02201 | 0.236 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.521 |
DOC_CKS1_1 | 350 | 355 | PF01111 | 0.232 |
DOC_CYCLIN_yCln2_LP_2 | 224 | 230 | PF00134 | 0.246 |
DOC_MAPK_gen_1 | 237 | 247 | PF00069 | 0.251 |
DOC_MAPK_gen_1 | 363 | 371 | PF00069 | 0.283 |
DOC_MAPK_MEF2A_6 | 239 | 247 | PF00069 | 0.321 |
DOC_MAPK_MEF2A_6 | 336 | 344 | PF00069 | 0.249 |
DOC_MAPK_MEF2A_6 | 363 | 371 | PF00069 | 0.283 |
DOC_PP1_RVXF_1 | 186 | 192 | PF00149 | 0.296 |
DOC_PP1_RVXF_1 | 280 | 287 | PF00149 | 0.154 |
DOC_PP4_FxxP_1 | 153 | 156 | PF00568 | 0.449 |
DOC_PP4_FxxP_1 | 191 | 194 | PF00568 | 0.253 |
DOC_USP7_MATH_1 | 11 | 15 | PF00917 | 0.456 |
DOC_USP7_MATH_1 | 322 | 326 | PF00917 | 0.154 |
DOC_WW_Pin1_4 | 102 | 107 | PF00397 | 0.706 |
DOC_WW_Pin1_4 | 288 | 293 | PF00397 | 0.290 |
DOC_WW_Pin1_4 | 349 | 354 | PF00397 | 0.232 |
LIG_14-3-3_CanoR_1 | 142 | 151 | PF00244 | 0.329 |
LIG_14-3-3_CanoR_1 | 163 | 172 | PF00244 | 0.407 |
LIG_14-3-3_CanoR_1 | 282 | 287 | PF00244 | 0.337 |
LIG_Actin_WH2_2 | 248 | 264 | PF00022 | 0.296 |
LIG_BIR_III_2 | 328 | 332 | PF00653 | 0.232 |
LIG_BRCT_BRCA1_1 | 139 | 143 | PF00533 | 0.296 |
LIG_deltaCOP1_diTrp_1 | 280 | 286 | PF00928 | 0.369 |
LIG_FHA_1 | 102 | 108 | PF00498 | 0.745 |
LIG_FHA_1 | 44 | 50 | PF00498 | 0.381 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.438 |
LIG_LIR_Apic_2 | 190 | 194 | PF02991 | 0.259 |
LIG_LIR_Gen_1 | 280 | 290 | PF02991 | 0.343 |
LIG_LIR_Gen_1 | 291 | 302 | PF02991 | 0.268 |
LIG_LIR_Nem_3 | 140 | 144 | PF02991 | 0.273 |
LIG_LIR_Nem_3 | 145 | 151 | PF02991 | 0.269 |
LIG_LIR_Nem_3 | 176 | 181 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 201 | 205 | PF02991 | 0.271 |
LIG_LIR_Nem_3 | 280 | 286 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 291 | 297 | PF02991 | 0.307 |
LIG_NRBOX | 357 | 363 | PF00104 | 0.283 |
LIG_PALB2_WD40_1 | 181 | 189 | PF16756 | 0.369 |
LIG_PDZ_Class_2 | 405 | 410 | PF00595 | 0.531 |
LIG_Pex14_2 | 279 | 283 | PF04695 | 0.236 |
LIG_PTB_Apo_2 | 251 | 258 | PF02174 | 0.193 |
LIG_SH2_CRK | 294 | 298 | PF00017 | 0.404 |
LIG_SH2_NCK_1 | 16 | 20 | PF00017 | 0.445 |
LIG_SH2_SRC | 16 | 19 | PF00017 | 0.447 |
LIG_SH2_SRC | 296 | 299 | PF00017 | 0.369 |
LIG_SH2_STAP1 | 151 | 155 | PF00017 | 0.259 |
LIG_SH2_STAP1 | 294 | 298 | PF00017 | 0.236 |
LIG_SH2_STAP1 | 318 | 322 | PF00017 | 0.283 |
LIG_SH2_STAP1 | 33 | 37 | PF00017 | 0.587 |
LIG_SH2_STAT5 | 177 | 180 | PF00017 | 0.343 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.319 |
LIG_SH2_STAT5 | 296 | 299 | PF00017 | 0.236 |
LIG_SH3_3 | 103 | 109 | PF00018 | 0.671 |
LIG_SH3_3 | 263 | 269 | PF00018 | 0.253 |
LIG_SH3_3 | 350 | 356 | PF00018 | 0.232 |
LIG_SH3_5 | 292 | 296 | PF00018 | 0.337 |
LIG_SUMO_SIM_anti_2 | 122 | 128 | PF11976 | 0.236 |
LIG_SUMO_SIM_par_1 | 220 | 226 | PF11976 | 0.269 |
LIG_WW_3 | 25 | 29 | PF00397 | 0.567 |
MOD_CK1_1 | 108 | 114 | PF00069 | 0.535 |
MOD_CK1_1 | 166 | 172 | PF00069 | 0.271 |
MOD_CK1_1 | 401 | 407 | PF00069 | 0.387 |
MOD_CK1_1 | 86 | 92 | PF00069 | 0.515 |
MOD_CK2_1 | 167 | 173 | PF00069 | 0.334 |
MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.637 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.494 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.350 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.568 |
MOD_GSK3_1 | 330 | 337 | PF00069 | 0.335 |
MOD_GSK3_1 | 345 | 352 | PF00069 | 0.334 |
MOD_GSK3_1 | 395 | 402 | PF00069 | 0.345 |
MOD_GSK3_1 | 86 | 93 | PF00069 | 0.523 |
MOD_N-GLC_1 | 83 | 88 | PF02516 | 0.652 |
MOD_NEK2_1 | 198 | 203 | PF00069 | 0.331 |
MOD_NEK2_1 | 205 | 210 | PF00069 | 0.331 |
MOD_NEK2_1 | 334 | 339 | PF00069 | 0.216 |
MOD_NEK2_2 | 215 | 220 | PF00069 | 0.271 |
MOD_PIKK_1 | 11 | 17 | PF00454 | 0.585 |
MOD_PIKK_1 | 38 | 44 | PF00454 | 0.567 |
MOD_PKA_1 | 163 | 169 | PF00069 | 0.322 |
MOD_PKA_2 | 163 | 169 | PF00069 | 0.396 |
MOD_PKB_1 | 368 | 376 | PF00069 | 0.283 |
MOD_Plk_1 | 334 | 340 | PF00069 | 0.154 |
MOD_Plk_1 | 38 | 44 | PF00069 | 0.435 |
MOD_Plk_4 | 282 | 288 | PF00069 | 0.439 |
MOD_Plk_4 | 31 | 37 | PF00069 | 0.638 |
MOD_Plk_4 | 322 | 328 | PF00069 | 0.390 |
MOD_ProDKin_1 | 102 | 108 | PF00069 | 0.705 |
MOD_ProDKin_1 | 288 | 294 | PF00069 | 0.290 |
MOD_ProDKin_1 | 349 | 355 | PF00069 | 0.232 |
TRG_DiLeu_BaEn_1 | 217 | 222 | PF01217 | 0.271 |
TRG_DiLeu_BaEn_1 | 357 | 362 | PF01217 | 0.283 |
TRG_ENDOCYTIC_2 | 294 | 297 | PF00928 | 0.404 |
TRG_ENDOCYTIC_2 | 33 | 36 | PF00928 | 0.628 |
TRG_ER_diArg_1 | 22 | 24 | PF00400 | 0.637 |
TRG_ER_diArg_1 | 27 | 29 | PF00400 | 0.595 |
TRG_ER_diArg_1 | 272 | 274 | PF00400 | 0.322 |
TRG_ER_diArg_1 | 367 | 370 | PF00400 | 0.283 |
TRG_ER_diArg_1 | 94 | 97 | PF00400 | 0.465 |
TRG_Pf-PMV_PEXEL_1 | 142 | 146 | PF00026 | 0.283 |
TRG_Pf-PMV_PEXEL_1 | 73 | 77 | PF00026 | 0.439 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P520 | Leptomonas seymouri | 57% | 100% |
A0A0S4JMK2 | Bodo saltans | 33% | 81% |
A0A1X0NG89 | Trypanosomatidae | 41% | 100% |
A0A3S7WXG3 | Leishmania donovani | 89% | 100% |
A0A422NW44 | Trypanosoma rangeli | 42% | 99% |
A4HCM8 | Leishmania braziliensis | 74% | 100% |
A4I052 | Leishmania infantum | 89% | 100% |
O02218 | Caenorhabditis elegans | 27% | 100% |
O22975 | Arabidopsis thaliana | 24% | 98% |
P53264 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 21% | 92% |
P91143 | Caenorhabditis elegans | 30% | 100% |
Q0J0A4 | Oryza sativa subsp. japonica | 23% | 99% |
Q4QBG1 | Leishmania major | 79% | 100% |
Q5EA59 | Bos taurus | 32% | 100% |
Q5EE05 | Sus scrofa | 27% | 100% |
Q6QA69 | Rattus norvegicus | 28% | 100% |
Q8TB40 | Homo sapiens | 31% | 100% |
Q8VD66 | Mus musculus | 31% | 100% |
Q8WTS1 | Homo sapiens | 28% | 100% |
V5B077 | Trypanosoma cruzi | 43% | 100% |